https://www.selleckchem.com/pr....oducts/cerdulatinib-
05). The prevalence of irritative symptoms was higher among patients with MS, EDSS score ≤ 3, disease duration of less than 5 years, and with clinically isolated syndrome. In addition, the prevalence of mixed symptoms was higher among patients with MS of over 30 years of age with a Pre-high school degree, severe disability, disease duration of over 10 years, and progressive MS; the difference was statistically significant (P less then 0.05). There was a difference in the combined dimensions of physical and mental
Like
Comment
Share
